{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:06:56Z","timestamp":1771297616400,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"James Madison University Department of Biology"},{"name":"Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07654-4","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:14:59Z","timestamp":1769163299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A genome-wide CRISPR\/Cas9 screen reveals novel positive regulators of FTY720 sensitivity in acute lymphoblastic leukemia cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Jaira","family":"Ferreira de Vasconcellos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Cubbage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurav","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"4","key":"7654_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.hoc.2009.04.009","volume":"23","author":"M Onciu","year":"2009","unstructured":"Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(4):655\u201374.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"7654_CR2","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","volume":"20","author":"DT Teachey","year":"2019","unstructured":"Teachey DT, Pui CH. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20(3):e142\u201354.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"7654_CR3","first-page":"S50","volume":"225","author":"A M\u00f6ricke","year":"2013","unstructured":"M\u00f6ricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, et al. Prediction of outcome by early response in childhood acute lymphoblastic leukemia. Klin Padiatr. 2013;225(Suppl 1):S50\u201356.","journal-title":"Klin Padiatr"},{"issue":"4","key":"7654_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bjhh.2015.03.009","volume":"37","author":"DW Lustosa de Sousa","year":"2015","unstructured":"Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante F\u00e9lix FH, de Oliveira Lopes MV. Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol E Hemoter. 2015;37(4):223\u20139.","journal-title":"Rev Bras Hematol E Hemoter"},{"issue":"4","key":"7654_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3324\/haematol.2009.014274","volume":"95","author":"A Oriol","year":"2010","unstructured":"Oriol A, Vives S, Hern\u00e1ndez-Rivas JM, Tormo M, Heras I, Rivas C, et al. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group. Haematologica. 2010;95(4):589\u201396.","journal-title":"Haematologica"},{"issue":"10230","key":"7654_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet Lond Engl. 2020;395(10230):1146\u201362.","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"7654_CR7","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524\u201339.","journal-title":"Haematologica"},{"issue":"16","key":"7654_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood.2019004043","volume":"136","author":"SP Hunger","year":"2020","unstructured":"Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 2020;136(16):1803\u201312.","journal-title":"Blood"},{"issue":"12","key":"7654_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15(12):554.","journal-title":"Genome Biol"},{"key":"7654_CR10","doi-asserted-by":"publisher","first-page":"1284610","DOI":"10.3389\/fphar.2023.1284610","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wang H, Yan Q, Cui J, Chen Y, Ruan S, et al. Genome-wide CRISPR\/Cas9 screening for drug resistance in tumors. Front Pharmacol. 2023;14:1284610.","journal-title":"Front Pharmacol"},{"issue":"2","key":"7654_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP. Mechanism of action of oral Fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol. 2010;33(2):91\u2013101.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"7654_CR12","doi-asserted-by":"publisher","first-page":"10707","DOI":"10.1007\/s13277-014-2386-y","volume":"35","author":"L Zhang","year":"2014","unstructured":"Zhang L, Wang H, Zhu J, Ding K, Xu J. FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K\/AKT\/mTOR\/p70S6K signaling pathway. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2014;35(11):10707\u201314.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"1","key":"7654_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/0008-5472.CAN-05-2001","volume":"66","author":"K LaMontagne","year":"2006","unstructured":"LaMontagne K, Littlewood-Evans A, Schnell C, O\u2019Reilly T, Wyder L, Sanchez T, et al. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res. 2006;66(1):221\u201331.","journal-title":"Cancer Res"},{"key":"7654_CR14","doi-asserted-by":"crossref","unstructured":"Wolf AM, Eller K, Zeiser R, D\u00fcrr C, Gerlach UV, Sixt M et al. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. J Immunol Baltim Md. 1950. 2009;183(6):3751\u201360.","DOI":"10.4049\/jimmunol.0901011"},{"issue":"1","key":"7654_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2006-10-053884","volume":"111","author":"Q Liu","year":"2008","unstructured":"Liu Q, Zhao X, Frissora F, Ma Y, Santhanam R, Jarjoura D, et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia\/lymphoma. Blood. 2008;111(1):275\u201384.","journal-title":"Blood"},{"issue":"5","key":"7654_CR16","doi-asserted-by":"publisher","first-page":"e36429","DOI":"10.1371\/journal.pone.0036429","volume":"7","author":"CT Wallington-Beddoe","year":"2012","unstructured":"Wallington-Beddoe CT, Don AS, Hewson J, Qiao Q, Papa RA, Lock RB, et al. Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia. PLoS ONE. 2012;7(5):e36429.","journal-title":"PLoS ONE"},{"issue":"6166","key":"7654_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343(6166):84\u20137.","journal-title":"Science"},{"issue":"13","key":"7654_CR18","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1074\/jbc.AC119.011170","volume":"295","author":"S Majumder","year":"2020","unstructured":"Majumder S, Kono M, Lee YT, Byrnes C, Li C, Tuymetova G, et al. A genome-wide CRISPR\/Cas9 screen reveals that the Aryl hydrocarbon receptor stimulates sphingolipid levels. J Biol Chem. 2020;295(13):4341\u20139.","journal-title":"J Biol Chem"},{"issue":"8","key":"7654_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783\u20134.","journal-title":"Nat Methods"},{"issue":"1","key":"7654_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, K\u00f6ster J, Xu H, Chen CH, Xiao T, Liu JS, et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 2015;16(1):281.","journal-title":"Genome Biol"},{"issue":"9","key":"7654_CR21","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.3390\/ijms11093087","volume":"11","author":"F Wang","year":"2010","unstructured":"Wang F, Tan W, Guo D, Zhu X, Qian K, He S. Altered expression of signaling genes in Jurkat cells upon FTY720 induced apoptosis. Int J Mol Sci. 2010;11(9):3087\u2013105.","journal-title":"Int J Mol Sci"},{"key":"7654_CR22","doi-asserted-by":"crossref","unstructured":"Hagihara K, Kinoshita K, Ishida K, Hojo S, Kameoka Y, Satoh R et al. A genome-wide screen for FTY720-sensitive mutants reveals genes required for ROS homeostasis. Microb Cell 4(12):390\u2013401.","DOI":"10.15698\/mic2017.12.601"},{"issue":"11","key":"7654_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-019-2080-5","volume":"10","author":"MM Young","year":"2019","unstructured":"Young MM, Bui V, Chen C, Wang HG. FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia. Cell Death Dis. 2019;10(11):847.","journal-title":"Cell Death Dis"},{"key":"7654_CR24","doi-asserted-by":"publisher","first-page":"114365","DOI":"10.1016\/j.bcp.2020.114365","volume":"184","author":"S Nirgude","year":"2021","unstructured":"Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol. 2021;184:114365.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"7654_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2011.05.013","volume":"309","author":"B Chen","year":"2011","unstructured":"Chen B, Rao X, House MG, Nephew KP, Cullen KJ, Guo Z. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett. 2011;309(1):37\u201345.","journal-title":"Cancer Lett"},{"issue":"12","key":"7654_CR26","doi-asserted-by":"publisher","first-page":"e81907","DOI":"10.1371\/journal.pone.0081907","volume":"8","author":"K Hagihara","year":"2013","unstructured":"Hagihara K, Kita A, Mizukura A, Yao M, Kitai Y, Kunoh T, et al. Fingolimod (FTY720) stimulates Ca(2+)\/calcineurin signaling in fission yeast. PLoS ONE. 2013;8(12):e81907.","journal-title":"PLoS ONE"},{"issue":"4","key":"7654_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/gtc.12134","volume":"19","author":"K Hagihara","year":"2014","unstructured":"Hagihara K, Mizukura A, Kitai Y, Yao M, Ishida K, Kita A, et al. FTY720 stimulated ROS generation and the Sty1\/Atf1 signaling pathway in the fission yeast Schizosaccharomyces Pombe. Genes Cells Devoted Mol Cell Mech. 2014;19(4):325\u201337.","journal-title":"Genes Cells Devoted Mol Cell Mech"},{"issue":"1","key":"7654_CR28","first-page":"290","volume":"37","author":"C Zhou","year":"2018","unstructured":"Zhou C, Bi F, Yuan J, Yang F, Sun S. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6. J Exp Clin Cancer Res CR. 2018;37(1):290.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"1","key":"7654_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13027-021-00402-2","volume":"16","author":"H Xie","year":"2021","unstructured":"Xie H, He Y, Wu Y, Lu Q. Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4. Infect Agent Cancer. 2021;16(1):63.","journal-title":"Infect Agent Cancer"},{"issue":"13","key":"7654_CR30","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1038\/emboj.2011.155","volume":"30","author":"Y Cui","year":"2011","unstructured":"Cui Y, He S, Xing C, Lu K, Wang J, Xing G, et al. SCFFBXL15 regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1. EMBO J. 2011;30(13):2675\u201389.","journal-title":"EMBO J"},{"issue":"19","key":"7654_CR31","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1074\/jbc.R116.715193","volume":"291","author":"MS Ioannou","year":"2016","unstructured":"Ioannou MS, McPherson PS. Regulation of cancer cell behavior by the small GTPase Rab13. J Biol Chem. 2016;291(19):9929\u201337.","journal-title":"J Biol Chem"},{"issue":"1","key":"7654_CR32","doi-asserted-by":"publisher","first-page":"16859","DOI":"10.1038\/s41598-023-43699-2","volume":"13","author":"XD Zhang","year":"2023","unstructured":"Zhang XD, Liu ZY, Luo K, Wang XK, Wang MS, Huang S, et al. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis. Sci Rep. 2023;13(1):16859.","journal-title":"Sci Rep"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07654-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07654-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07654-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:02:43Z","timestamp":1771293763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07654-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7654"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07654-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Biosafety Committee, and were performed following National Institutes of Health guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}